Back Memory
Chapters (30)
  1. MemoryLois McMaster Bujold
  2. CHAPTER ONE
  3. CHAPTER TWO
  4. CHAPTER THREE
  5. CHAPTER FOUR
  6. CHAPTER FIVE
  7. CHAPTER SIX
  8. CHAPTER SEVEN
  9. CHAPTER EIGHT
  10. CHAPTER NINE
  11. CHAPTER TEN
  12. CHAPTER ELEVEN
  13. CHAPTER TWELVE
  14. CHAPTER THIRTEEN
  15. CHAPTER FOURTEEN
  16. CHAPTER FIFTEEN
  17. CHAPTER SIXTEEN
  18. CHAPTER SEVENTEEN
  19. CHAPTER EIGHTEEN
  20. CHAPTER NINETEEN
  21. CHAPTER TWENTY
  22. CHAPTER TWENTY-ONE
  23. CHAPTER TWENTY-TWO
  24. CHAPTER TWENTY-THREE
  25. CHAPTER TWENTY-FOUR
  26. CHAPTER TWENTY-FIVE
  27. CHAPTER TWENTY-SIX
  28. CHAPTER TWENTY-SEVEN
  29. CHAPTER TWENTY-EIGHT
  30. CHAPTER TWENTY-NINE

"Your first question I cannot answer. But I could read much of its product history off its molecular structure. First of all, whoever made this did not begin from scratch. This is a modification of an existing, patented apoptotic organism originally designed to destroy neural plaque. The galactic patent code for that perfectly legitimate medical application was still readable on some of the molecular fragments. The modified prokaryote, however, bore no identifications of laboratories of origin, licensing, or patent markings. The original patent is about ten years old, by the way, which gives you the first point in your time-window problem."

"That was going to be my next question," said Miles. "I hope we can narrow things down more than that."

"Of course. But you see how much we learn already, just from the codes and their absences. The original medical prokaryote was pirated for the new purpose, and the people who modified it were obviously not concerned with legitimizing it for mass trade. It has all the signs of being a one-off job for a one-time customer."

"Illegal Jacksonian work, by chance?" asked Miles. You would know.

"The kind of shortcuts taken in its design strongly suggest it. I'm not personally familiar with it, unfortunately."

Not something from Bharaputra Labs, Weddell/Canaba's former employer, then. That would have been a happy chance. But there were a dozen other Jacksonian houses who might have taken on small work like this. For a fee.

"So how much did this cost to make? Or rather, to have made?"

"Mm . . ." Weddell stared thoughtfully into space. "Actual lab costs, something under fifty thousand Betan dollars. Who knows what the markup might have been. Any special demand for secrecy on the part of its purchasers would have driven the cost up, oh, about five-fold. Or more, depending on what the market would bear."

Not the work of a lone nut, then, unless he were a fabulously rich lone nut. An organization, perhaps. Komarran terrorists sprang to mind—they always did, unfortunately.

"Could this be Cetagandan work?" asked General Haroche.

"Oh, no, I don't think so," said Weddell. "It's not in their style at all. Genetically speaking. Cetagandan work is distinguished by its quality, originality, and, how shall I put it, elegance. This is, by comparison, slapdash. Effective, mind you, but slapdash. On a molecular level."

Illyan's lips twisted, but he said nothing.

"The self-destruct sequencing," Weddell went on, "could have been a safety-check, simply left over from the original design. Or . . . it could have been deliberately intended to destroy the evidence."

"Can you tell which?"

"There were some slight modifications in it, compared to the original medical prokaryote . . . it was deliberately left in the design, anyway. I can give you facts, my lord; I cannot give you the intentions of unknown persons."

That's my job, right. "So . . . when was it administered to Illyan? And how?"

"Administered is an assumptive term, though under the circumstances probably allowable. The first gross symptoms of breakdown were when, again?"